Pediatric Multiple Organ Dysfunction Syndrome

Pediatric Critical Care

Volumn , Issue , 2006, Pages 1494-1507

  Cengiz, Pelin ^a   Zimmerman, Jerry J ^a  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884423975     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032301808-1.50100-0     Document Type: Chapter

References (139)

1. DuPont HL, DuPont SW Infections due to gram-negative organism: an analysis of 860 patients with bacteremia at University of Minnesota Medical Center. Medicine (Baltimore) 1968, 48:307.
2. Pollard AJ, Britto J, Nadel S, et al. Emergency management of meningococcal disease. Arch Dis Child 1999, 80:290-296.
3. Carcillo JA Pediatric septic shock and multiple organ failure. Crit Care Clin 2003, 19:413-440.
4. Wilkinson JD, Pollack MM, Glass NL, et al. Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr 1987, 111:324-328.
5. Bell RC, Coalson JJ, Smith JD, et al. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1983, 99:293-298.
6. Tantalean JA, Leon RJ, Santos AA, et al. Multiple organ dysfunction syndrome in children. Pediatr Crit Care Med 2003, 4:181-185.
7. Chandra RK Nutrition and immunology: from the clinic to cellular biology and back again. Proc Nutr Soc 1999, 58:681-683.
8. Scrimshaw NS, San Giovanni JP Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr 1997, 66:464S-477S.
9. Kutko MC, Calarco MP, Flaherty MB, et al. Mortality rates in pediatric septic shock with and without multiple organ system failure. Pediatr Crit Care Med 2003, 4:333-337.
10. Duke TD, Butt W, South M Predictors of mortality and multiple organ failure in children with sepsis. Intensive Care Med 1997, 23:684-692.
11. Watson RS, Carcillo JA, Linde-Zwirble WT, et al. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003, 167:695-701.
12. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ system failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
13. Hayden WR Sepsis and organ failure definitions and guidelines. Crit Care Med 1993, 21:1612-1613. letter.
14. Goldstein B, Giroir B, Randolph A International Consensus Conference Panel. International pediatric severe sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005, 6:2-8.
15. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32:858-871.
16. Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
17. Proulx F, Gauthier M, Nadeau D, et al. Timing and predictors of death in pediatric patients with multiple organ system failure. Crit Care Med 1994, 22:1025-1031.
18. Proulx F, Fayon M, Farrell CA, et al. Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest 1996, 109:1033-1037.
19. Wilkinson JD, Pollack MM, Ruttiman UE, et al. Outcome of pediatric patients with multiple organ system failure. Crit Care Med 1986, 14:271-274.
20. Duke TD, Butt W, South M Predictors of mortality and multiple organ failure in children with sepsis. Intensive Care Med 1997, 23:684-692.
21. Proulx F, Proulx BB, Lacroix J Paediatric multiple organ dysfunction syndrome. Intensive Care World 1997, 14:78-82.
22. Lacroix J, Nadeau D, Laberge S, et al. frequency of upper gastrointestinal bleeding in a pediatric intensive care unit. Crit Care Med 1992, 20:35-42.
23. Bone RC Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996, 24:1125-1128.
24. Nichter MA, Nichter S-FJ, Costarino AT Pediatric multiple organ failure syndrome. Crit Care Med 1991, 19:S78. abstract.
25. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
26. Tilney NL, Bailey GL, Morgan AP Sequential system failure after rupture of abdominal aortic aneurysms: an unsolved problem in postoperative care. Ann Surg 1973, 178:117-122.
27. Darling GE, Duff JH, Mustard RA, et al. Multi-organ failure in critically ill patients. Can J Surg 1988, 31:172-176.
28. Tran DD, Groeneveld AB, van der Meulen J, et al. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 1990, 18:474-479.
29. Marshall WG, Dimick AR The natural history of major burns with multiple subsystem failure. J Trauma 1983, 23:102-105.
30. Fry DE, Pearlstein L, Fulton RL, et al. Multiple system organ failure. The role of uncontrolled infection. Arch Surg 1980, 115:136-140.
31. Faist E, Baue AE, Dittmer H, et al. Multiple organ failure in polytrauma patients. J Trauma 1983, 23:775-787.
32. Fry D Multiple system organ failure 1992, Mosby, St. Louis.
33. Vincent JL, Ferreira F, Moreno R Scoring systems for assessing organ dysfunction and survival. Crit Care Clin 2000, 16:353-366.
34. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991, 100:1619-1636.
35. Pollack MM, Patel KM, Ruttimann UE PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 1996, 24:743-752.
36. Pollack MM, Ruttimann UE, Getson PR Pediatric risk of mortality (PRISM) score. Crit Care Med 1988, 16:1110-1116.
37. Pollack MM, Cuerdon TT, Patel KM, et al. Impact of quality-of-care factors on pediatric intensive care unit mortality. JAMA 1994, 272:941-946.
38. Le Gall JR, Loirat P, Alperovitch A, et al. A simplified acute physiology score for ICU patients. Crit Care Med 1984, 12:975-977.
39. Lemeshow S, Klar J, Teres D Outcome prediction for individual intensive care patients: useful, misused, or abused?. Intensive Care Med 1995, 21:770-776.
40. Predicting outcome in ICU patients 2nd European Consensus Conference in Intensive Care Medicine. Intensive Care Med 1994, 20:390-397.
41. Petros AJ, Marshall JC, van Saene HK Should morbidity replace mortality as an endpoint for clinical trials in intensive care. Lancet 1995, 345:369-371.
42. Le Gall JR, Lemeshow S, Saulnier F A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963.
43. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
44. Le Gall JR, Klar J, Lemeshow S, et al. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit, ICU Scoring Group. JAMA 1996, 276:802-810.
45. Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995, 23:1638-1652.
46. Leteurtre S, Martinot A, Duhamel A, et al. Development of a pediatric multiple organ dysfunction score: use of two strategies. Med Decision Making 1999, 19:399-410.
47. Leteurtre S, Martinot A, Duhamel A, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score, prospective, observational, multicenter study. Lancet 2003, 362:192-197.
48. Despond O, Proulx F, Carcillo JA, et al. Pediatric sepsis and multiple organ dysfunction syndrome. Curr Opin Pediatr 2001, 13:247-253.
49. Livingston DH, Mosenthal AC, Deitch EA Sepsis and multiple organ dysfunction syndrome: a clinical-mechanistic overview. New Horiz 1995, 3:257-266.
50. Balk RA Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin 2000, 16:337-352.
51. Reid CL, Perrey C, Pravica V, et al. Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome. Crit Care Med 2002, 30:2216-2221.
52. Schroder O, Alexander L, Held B, et al. Association of interleukin-10 promotor polymorphism with the incidence of multiple organ dysfunction following major trauma: results of a prospective pilot study. Shock 2004, 21:306-310.
53. Zimmerman JJ A question of balance. Crit Care Med 1999, 27:7-8.
54. Godin PJ, Buchman TG Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 1996, 24:1107-1116.
55. Goldstein B, Fiser DH, Kelly MM, et al. Decomplexification in critical illness and injury: relationship between heart rate variability, severity of illness, and outcome. Crit Care Med 1998, 26:352-357.
56. Buchman TG, Cobb JP, Lapedes AS, Kepler TB Complex systems analysis: a tool for shock research. Shock 2001, 16:248-251.
57. Tibby SM, Frndova H, Durward A, Cox P Novel method to quantify loss of heart rate variability in pediatric multiple organ failure. Crit Care Med 2003, 31:2059-2067.
58. Aird WC Endothelium as an organ system. Crit Care Med 2004, 32(suppl):S271-S279.
59. Hinshaw LB Sepsis/septic shock. Participation of the microcirculation. Crit Care Med 1996, 24:1072-1078.
60. Fisher AB Shear stress and endothelial cell activation. Crit Care Med 2002, 30(suppl):S192-S197.
61. Menger M Capillary dysfunction in striated muscle ischemia-reperfusion: on the mechanism of capillary 'no-reflow.'. Shock 1997, 8:2-7.
62. Verrier E The microvascular cell and ischemia-reperfusion injury. J Cardiovasc Pharmacol 1996, 27(suppl):S26-S30.
63. Lum H, Malik AB Regulation of vascular endothelial barrier function. Am J Physiol (Lung Cell Molec Physiol) 1994, 267:L223-L241.
64. Ueno H, Hirasawa H, Oda S, et al. Coagulation/fibrinolysis abnormality and vascular endothelial damage in the pathogenesis of thrombocytopenic multiple organ failure. Crit Care Med 2002, 30:2248-3242.
65. Tamion F, Richard V, Sauger F, et al. Gastric mucosal acidosis and cytokine release in patients with septic shock. Crit Care Med 2003, 31:2137-2143.
66. Zimmerman JJ Oxyradical pathophysiology. Advances in pediatrics 1994, Mosby-Yearbook, St. Louis. L.A. Barness (Ed.).
67. Saran M To what end does nature produce superoxide? NADPH oxidase as an autrine modifier of membrane phospholipids generating paracrine lipid messengers. Free Radic Res 2003, 37:1045-1059.
68. Lassegue B, Clempus RE Vascular NAD(P)H oxidases: specific features, expression and regulation. Am J Physiol Regul Integr Comp Physiol 2003, 285:R277-R297.
69. Terada LS Oxidative stress and endothelial activation. Crit Care Med 2002, 30(suppl):S186-S191.
70. Janiszewski M, do Carmo A, Pedro MA, et al. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: a novel vascular redox pathway. Crit Care Med 2004, 32:818-825.
71. Giulivi C Characterization and function of mitochondrial nitric-oxide synthase. Free Radic Biol Med 2003, 15:397-408.
72. Alderton WK, Cooper CE, Knowles RG Nitric oxide syntheses: structure, function and inhibition. Biochem J 2001, 357:593-615.
73. Beckman JS, Koppenol WH Nitric oxide, superoxide, and peroxynitrite: the good, the bad and the ugly. Am J Physiol Cell Physiol 1996, 271:C1424-C1437.
74. Radi R, Peluffo G, Alvarez MN, et al. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 2001, 30:463-488.
75. Szabo C Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 2003, 11:140-141.
76. Szabo C DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. Free Radic Biol Med 1996, 21:855-869.
77. Katusic ZS Superoxide anion and regulation of arterial tone. Free Radic Biol Med 1996, 20:443-448.
78. McCord JM Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985, 312:159-163.
79. Millar TM Xanthine oxidase is a peroxynitrite synthase: newly identified roles for a very old enzyme. Redox Report 2002, 7:1-6.
80. Repine JE, Cheronis JC, Rodell TC, et al. Pulmonary oxygen toxicity and ischemia-reperfusion injury. Am Rev Respir Dis 1987, 136:483-485.
81. Otterbein L, Choi AMK Hemoxygenase: colors of defense against cellular stress. Am J Physiol 2000, 279:L1029-L1037.
82. Taylor DE, Ghio AJ, Piantidosi CA Reactive oxygen species produced by liver mitochondria of rats in sepsis. Arch Biochem Biophys 1995, 316:70-76.
83. Kowaltowski AJ, Vercesi AE Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 1999, 26:463-471.
84. Fink M Cytopathic hypoxia: is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration?. Crit Care Clin 2002, 18:165-175.
85. Crouser ED, Julian MW, Blaho OV, et al. Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 2002, 30:276-284.
86. Crouser ED, Julian MW, Huff JE, et al. Abnormal permeability of inner and outer mitochondrial membranes contributes independently to mitochondrial dysfunction in the liver during acute endotoxemia. Crit Care Med 2004, 32:478-488.
87. Babior BM, Lambeth JD, Nauseef W The neutrophil NADPH oxidase. Arch Biochem Biophys 2002, 397:342-344.
88. Granger DN Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 1988, 24:H1269-H1275.
89. Eppihimer MJ, Granger DN Ischemia/reperfusion-induced leukocyte-endothelial interactions in post-capillary venules. Shock 1997, 8:16-25.
90. Downey GP, Fialkow L, Fukushima T Initial interaction of leukocytes within the microvasculature: deformability, adhesion, and transmigration. New Horiz 1995, 3:219-228.
91. Weiss SJ Tissue destruction by neutrophils. N Engl J Med 1989, 320:365-376.
92. Kettle AJ, Winterbourn CC Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Report 1997, 3:3-15.
93. Ossanna PJ, Test ST, Matheson NR, et al. Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions. J Clin Invest 1986, 77:1939-1951.
94. Patrick DA, Moore EE, Moore FA, et al. Reduced PAF-acetylhydrolase activity is associated with post injury multiple organ failure. Shock 1997, 7:170-174.
95. Weiland JE, Davis WB, Holter JF, et al. Lung neutrophils in the adult respiratory distress syndrome. Am Rev Respir Dis 1986, 133:218-225.
96. Martin TR Neutrophils and lung injury: getting it right. J Clin Invest 2002, 110:1603-1605.
97. Matute-Bello G, Liles WC, Steinberg KP, et al. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999, 163:2217-2225.
98. Carlotta F, Re F, Polenatrutti N, et al. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992, 80:2012-2020.
99. Ertel W, Kee LM, Infanger M, et al. Circulating mediators in serum of injured patients with septic complications inhibit neutrophil apoptosis through up-regulation of protein-tyrosine phosphorylation. J Trauma 1998, 44:767-775.
100. Jimenez MF, Watson RW, Parodo J, et al. Disregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg 1997, 132:1263-1269.
101. Matute-Bello G, Martin TR Science review: apoptosis in acute lung injury. 2003, 7:355-358.
102. Machino T, Hashimoto S, Maruoka S, et al. Apoptosis signal-regulating kinase 1-mediated signaling pathway regulates hydrogen peroxide-induced apoptosis in human pulmonary vascular endothelial cells. Crit Care Med 2003, 31:2776-2781.
103. Le Tulzo YL, Pangault C, Gacouin A, et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 2002, 18:487-494.
104. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with septic shock and multiple organ dysfunction. Crit Care Med 1999, 27:1230-1251.
105. + T lymphocytes in humans. J Immunol 2001, 166:6952-6963.
106. Papathanassoglou EDE, Moynihan JA, McDermott MP, et al. Expression of Fas (CD 95) and Fas ligand on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival. Crit Care Med 2001, 29:709-718.
107. Doughty L, Clark RSB, Kaplan SS, et al. sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome. Pediatr Res 2002, 52:922-927.
108. Zeerleder S, Zwart B, Wuillemin WA, et al. Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003, 31:1947-1951.
109. Marsik C Regulation of Fas (APO-1, CD 95) and Fas ligand expression during systemic inflammation. Shock 2003, 20:493-496.
110. Hashimoto S, Kobayashi A, Kooguchi K, et al. Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med 2000, 161:237-243.
111. Liacos C, Katsaragakis S, Konstadoulakis MM, et al. Apoptosis in cells of bronchoalveolar lavage: a cellular reaction in patients who die with sepsis and respiratory failure. Crit Care Med 2001, 29:2310-2317.
112. Watson WR, Rotstein OD, Parodo J, et al. The IL-1 beta-converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1 beta. J Immunol 1998, 161:957.
113. Hack CE, Zeeleder S The endothelium in sepsis: source of and a target for inflammation. Crit Care Med 2001, 29(suppl):S21-S27.
114. DeBacker D Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002, 166:98-104.
115. Poschi JMB Endotoxin binding to erythrocyte membrane and erythrocyte deformability in human sepsis and in vitro. Crit Care Med 2003, 31:924-928.
116. Protein C pathways: bedside to bench. The Margaux V Conference on Critical Illness. Crit Care Med 2004, 32(suppl):S193-S341.
117. Nguyen T, Hall M, Han Y, et al. Microvascular thrombosis in pediatric multiple organ failure: is it a therapeutic target?. Pediatr Crit Care Med 2001, 2:187-196.
118. Nimah M, Brilli RJ Coagulation dysfunction in sepsis and multiple organ system failure. Crit Care Clin 2003, 19:441-448.
119. Carcillo JA, Davis AL, Zaritsky A Role of early fluid resuscitation in pediatric septic shock. JAMA 1991, 266:1242-1245.
120. Carcillo JA, Fields AI, Task Force Members Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002, 30:1365-1378.
121. Han YY, Carcillo JA, Dragotta MA, et al. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics 2003, 112:793-799.
122. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
123. Silliman CC, Moore EE, Johnson JL, et al. Transfusion of the injured patient: proceed with caution. Shock 2004, 21:291-299.
124. Doughty LA, Kaplan SS, Carcillo JA Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med 1996, 24:1137-1143.
125. Doughty L, Carcillo JA, Kaplan S, Janosky J Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis. Crit Care Med 1998, 26:157-162.
126. Hatherill M, Tibby SM, Turner C, et al. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med 2000, 28:2591-2594.
127. Whalen M, Doughty L, Carlos TM, et al. Intercellular adhesion molecule-1 and vascular cell adhesion molecule are increased in the plasma of children with sepsis-induced multiple organ failure. Crit Care Med 2000, 28:2600-2607.
128. Bernard GR, Vincent J-L, Laterre P-F, et al. Efficacy and safety of recombinant human activated protein c for severe sepsis. N Engl J Med 2001, 344:699-709.
129. Vincent J-L, Angus DC, Artigas A, et al. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med 2003, 31:834-840.
130. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
131. Didonato JA, Saatcioglu F, Karin M Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids. Am J Respir Crit Care Med 1996, 154:S11-S15.
132. Barnes PJ Mechanism of action of glucocorticoids in asthma. Am J Respir Crit Care Med 1996, 154:S21-S27.
133. Keh D, Boehnke T, Weber-Cartens S, et al. Immunologic and hemodynamic effects of 'low dose' hydrocortisone in septic shock. Am J Respir Crit Care Med 2003, 167:512-520.
134. Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared to traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-1308.
135. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically in patients. N Engl J Med 2001, 345:1359-1367.
136. Wasmuth HE, Kunz D, Graf J, et al. Hyperglycemia at admission to the intensive care unit is associated with elevated serum concentrations of interleukin-6 and reduced ex vivo secretion of tumor necrosis factor-alpha. Crit Care Med 2004, 32:1109-1114.
137. Das UN Insulin and the critically ill. Crit Care 2002, 6:262-263.
138. Baue AE Multiple organ failure, multiple organ dysfunction syndrome, and the systemic inflammatory response syndrome where do we stand?. Shock 1994, 2:385-397.
139. Baue AE, Durham R, Faist E Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), and multiple organ failure (MOF): are we winning the battle?. Shock 1998, 10:79-89.